(Date:5/20/2013)... Ras Al Khaimah, UAE (PRWEB) May 21, 2013 ... and private equity consultancy specializing in “game-changing” life science ... appointment of Ms. Dalia Dergham to its International Project ... certain to bring even greater multi-cultural depth to Grace ... more projects around the globe. , Ms. Dergham holds ...
(Date:5/20/2013)... , May 20, 2013 Today, at the ... Francisco , James McGough , ... at the Semel Institute for Neuroscience and Human Behavior ... Medicine at the University of California Los Angeles (UCLA), ... and Adolescent Psychopharmacology and ADHD at UCLA, presented the ...
(Date:5/20/2013)... SEATTLE , May 20, 2013 Pacific Biomarkers ... laboratory solutions for developers of biosimilars at the ... the Sheraton San Diego Hotel and Marina ... Attendees will have the opportunity to speak with company ... Development: Paths That Cross" on May 21 from 1-2 ...
(Date:5/20/2013)... HILL, N.C. , May 20, 2013 /PRNewswire/ ... company focused on developing differentiated antibiotics to meet ... infections, today announced that it presented data at ... in Philadelphia demonstrating the ... levofloxacin in Cempra,s prior Phase 2 clinical trial ...
Breaking Biology Technology:Dalia Dergham Joins Grace Century FZ LLC International Project Team 2Positive Results Reported for Phase I Clinical Trial at UCLA for the Treatment of ADHD in Children Using External Trigeminal Nerve Stimulation (eTNS) 2Positive Results Reported for Phase I Clinical Trial at UCLA for the Treatment of ADHD in Children Using External Trigeminal Nerve Stimulation (eTNS) 3Positive Results Reported for Phase I Clinical Trial at UCLA for the Treatment of ADHD in Children Using External Trigeminal Nerve Stimulation (eTNS) 4Positive Results Reported for Phase I Clinical Trial at UCLA for the Treatment of ADHD in Children Using External Trigeminal Nerve Stimulation (eTNS) 5Pacific Biomarkers and Clinigene International To Announce Laboratory Solutions for Developers of Biosimilars at 2013 AAPS/ National Biotechnology Conference 2Cempra Presents Post-Phase 2 Analysis of Solithromycin's Efficacy and Safety Results from Patients with Community Acquired Bacterial Pneumonia (CABP) 2For the quantitative determination of canine Interleukin 10,(IL-10) concentrations in cell culture supernates, canine serum,and plasma....
MOUSE ANTI HUMAN COMPLEMENT SC5B-9...
RABBIT ANTI NEOPTERIN...
MOUSE ANTI HUMAN MBP (67-74) Immunogen: Human myelin basic protein...
Biology Products:Biology NavigationMedical Navigation